Peter J. Dandliker

Statistics

Publications

Citations

3.1K

H-Index

Active since

1994

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Abbott Fund

California Institute of Technology

Abbott (United States)

Peter J. Dandliker is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in drug discovery, medicinal chemistry, and pharmacy.

ORCID

Publications per year

1994–2022

Publications

An orally available non-nucleotide STING agonist with antitumor activity

Bo‐Sheng Pan, Samanthi A. Perera, Jennifer Piesvaux et al. · Science · 2020 · 660 citations

Medicine, Medicinal Chemistry, Pharmacology +16

Oxidative Thymine Dimer Repair in the DNA Helix

Peter J. Dandliker, R. Erik Holmlin, Jacqueline K. Barton · Science · 1997 · 433 citations

Life Sciences, Biochemistry, Molecular Biology +15

Charge Transfer through the DNA Base Stack

R. Erik Holmlin, Peter J. Dandliker, Jacqueline K. Barton · Angewandte Chemie International Edition in English · 1997 · 317 citations

Life Sciences, Chemistry, Molecular Biology +15

Dendritic Porphyrins: Modulating Redox Potentials of Electroactive Chromophores with Pendant Multifunctionality

Peter J. Dandliker, François Diederich, Maurice Gross et al. · Angewandte Chemie International Edition in English · 1994 · 263 citations

Life Sciences, Biochemistry, Chemistry +16

Nanoscale synthesis and affinity ranking

Nathan J. Gesmundo, Bérengère Sauvagnat, Patrick J. Curran et al. · Nature · 2018 · 214 citations

Natural Sciences, Chemistry, Materials Science +13

1–5 of 24